Alligator Bioscience AB - Asset Resilience Ratio

Latest as of December 2025: 56.24%

Alligator Bioscience AB (ATORX) has an Asset Resilience Ratio of 56.24% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Alligator Bioscience AB (ATORX) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Skr62.20 Million

≈ $6.69 Million USD Cash + Short-term Investments

Total Assets

Skr110.60 Million

≈ $11.90 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2025)

This chart shows how Alligator Bioscience AB's Asset Resilience Ratio has changed over time. See ATORX net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Alligator Bioscience AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Alligator Bioscience AB.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr62.20 Million	56.24%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr62.20 Million	56.24%

Asset Resilience Insights

Very High Liquidity: Alligator Bioscience AB maintains exceptional liquid asset reserves at 56.24% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Alligator Bioscience AB Industry Peers by Asset Resilience Ratio

Compare Alligator Bioscience AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Alligator Bioscience AB (2007–2025)

The table below shows the annual Asset Resilience Ratio data for Alligator Bioscience AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	56.24%	Skr62.20 Million ≈ $6.69 Million	Skr110.60 Million ≈ $11.90 Million	-5.40pp
2024-12-31	61.64%	Skr64.31 Million ≈ $6.92 Million	Skr104.34 Million ≈ $11.23 Million	+5.82pp
2023-12-31	55.82%	Skr66.12 Million ≈ $7.12 Million	Skr118.45 Million ≈ $12.75 Million	-1.56pp
2022-12-31	57.38%	Skr97.31 Million ≈ $10.47 Million	Skr169.58 Million ≈ $18.25 Million	-26.10pp
2021-12-31	83.48%	Skr278.15 Million ≈ $29.93 Million	Skr333.20 Million ≈ $35.86 Million	+15.46pp
2020-12-31	68.02%	Skr103.34 Million ≈ $11.12 Million	Skr151.94 Million ≈ $16.35 Million	-28.36pp
2019-12-31	96.38%	Skr299.85 Million ≈ $32.27 Million	Skr311.13 Million ≈ $33.48 Million	+20.98pp
2018-12-31	75.40%	Skr383.13 Million ≈ $41.23 Million	Skr508.16 Million ≈ $54.69 Million	+1.85pp
2017-12-31	73.55%	Skr472.92 Million ≈ $50.89 Million	Skr643.03 Million ≈ $69.20 Million	-20.51pp
2016-12-31	94.06%	Skr659.14 Million ≈ $70.93 Million	Skr700.78 Million ≈ $75.42 Million	+94.06pp
2015-12-31	0.00%	Skr1.00K ≈ $107.62	Skr416.26 Million ≈ $44.80 Million	-51.18pp
2008-12-31	51.18%	Skr10.00 Million ≈ $1.08 Million	Skr19.54 Million ≈ $2.10 Million	-29.54pp
2007-12-31	80.72%	Skr38.62 Million ≈ $4.16 Million	Skr47.85 Million ≈ $5.15 Million	--

pp = percentage points

About Alligator Bioscience AB

ST:ATORX Sweden Biotechnology

Market Cap

$11.36 Million

Skr105.52 Million SEK

Market Cap Rank

#26740 Global

#582 in Sweden

Share Price

Skr0.17

Change (1 day)

-0.94%

52-Week Range

Skr0.16 - Skr7.20

All Time High

Skr55.78